Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indiana flea market sales

This article was originally published in The Tan Sheet

Executive Summary

Bill prohibiting the sale of OTCs, personal care products, cosmetics and medical devices in flea markets signed into law by Gov. Frank O'Bannon (R) May 3. Introduced by Rep. Michael Dvorak (D-St. Joseph), H 1495 passed the House 94-3 on Feb. 24 and the Senate floor 40-10 on April 12. The legislation was introduced for the first time earlier in the session. The Indiana Retail Association lobbied in favor of the bill's passage. A similar bill in Connecticut (No. 1103), which would restrict all sales of drugs, devices, cosmetics, baby food and infant formulas at flea markets, except if sold by a "manufacturer's or distributor's representative," is before the state's Joint Committee on Judiciary. A comparable bill also has been introduced in California ("The Tan Sheet" March 8, In Brief)
Advertisement

Related Content

Flea markets
Flea markets
Flea markets

Topics

Advertisement
UsernamePublicRestriction

Register

PS089779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel